BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 34.0] [Reference Citation Analysis]
Number Citing Articles
1 Tan M, Zhang W, Zhou H, Liu Y, Lu T, Zhang Y, Li C, Yang Y, Wu Y, Hu H, Li Y, Yang F, Lin S. VariScreen secures the screening of high-risk varices in patients with hepatitis B virus-related cirrhosis beyond Baveno VI criteria. Front Physiol 2022;13:1006657. [DOI: 10.3389/fphys.2022.1006657] [Reference Citation Analysis]
2 Yokoyama K, Fukuda H, Yamauchi R, Higashi M, Miyayama T, Higashi T, Uchida Y, Shibata K, Tsuchiya N, Fukunaga A, Umeda K, Takata K, Tanaka T, Shakado S, Sakisaka S, Hirai F. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina 2022;58:1276. [DOI: 10.3390/medicina58091276] [Reference Citation Analysis]
3 Zhang Q, Wu W, Mei X, Zhang F, Ren X, Kong D. Efficient Initial Eradication of Large Esophageal Varices by Balloon-compression Endoscopic Injection Sclerotherapy. Surg Laparosc Endosc Percutan Tech 2022. [PMID: 36044334 DOI: 10.1097/SLE.0000000000001092] [Reference Citation Analysis]
4 Feraille E, Sassi A, Olivier V, Arnoux G, Martin PY. Renal water transport in health and disease. Pflugers Arch 2022;474:841-52. [PMID: 35678906 DOI: 10.1007/s00424-022-02712-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lee Y, Yoo KD, Baek SH, Kim YG, Kim HJ, Ryu JY, Paek JH, Suh SH, Oh SW, Lee J, Jhee JH, Suh J, Yang EM, Park YH, Kim YL, Choi M, Oh K, Kim S; on behalf of the Hyponatremia Guideline Development Group. Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia. Kidney Res Clin Pract 2022;41:S1-S30. [DOI: 10.23876/j.krcp.33.666] [Reference Citation Analysis]
6 Nagel M, Labenz C, Dobbermann H, Czauderna C, Wallscheid NC, Schattenberg JM, Wörns MA, Galle PR, Marquardt JU. Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation. Eur J Gastroenterol Hepatol 2022. [PMID: 35895982 DOI: 10.1097/MEG.0000000000002418] [Reference Citation Analysis]
7 Shigefuku R, Takahashi H, Watanabe T, Hattori N, Ikeda H, Matsunaga K, Ehira T, Suzuki T, Matsumoto N, Okuse C, Iwasa M, Nakagawa H, Itoh F, Suzuki M. Effects of endoscopic injection sclerotherapy for esophagogastric varices on portal hemodynamics and liver function. BMC Gastroenterol 2022;22:350. [PMID: 35864442 DOI: 10.1186/s12876-022-02422-7] [Reference Citation Analysis]
8 Okushin K, Tateishi R, Takahashi A, Uchino K, Nakagomi R, Nakatsuka T, Minami T, Sato M, Fujishiro M, Hasegawa K, Eguchi Y, Kanto T, Kubo S, Yoshiji H, Miyata H, Izumi N, Kudo M, Koike K. Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL). J Gastroenterol 2022. [PMID: 35788887 DOI: 10.1007/s00535-022-01893-5] [Reference Citation Analysis]
9 Häussinger D, Dhiman RK, Felipo V, Görg B, Jalan R, Kircheis G, Merli M, Montagnese S, Romero-Gomez M, Schnitzler A, Taylor-Robinson SD, Vilstrup H. Hepatic encephalopathy. Nat Rev Dis Primers 2022;8:43. [PMID: 35739133 DOI: 10.1038/s41572-022-00366-6] [Reference Citation Analysis]
10 Liu B, Li G, Li S. Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding. Disease Markers 2022;2022:1-6. [DOI: 10.1155/2022/2940578] [Reference Citation Analysis]
11 Premkumar M, Anand AC. Overview of Complications in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mcmurry H, Sabile JM, Elstrott B, Chobrutskiy B, Mohinani A, Patel S, Gowda S, Martens K, Shatzel J. Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy. J Clin Gastroenterol 2022. [PMID: 35537133 DOI: 10.1097/MCG.0000000000001713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kaibori M, Hiraoka A, Iida H, Komeda K, Hirokawa F, Ueno M, Kosaka H, Matsui K, Sekimoto M. Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan. Cancers (Basel) 2022;14:2091. [PMID: 35565221 DOI: 10.3390/cancers14092091] [Reference Citation Analysis]
15 Eso Y. Questionnaire-based approach to sleep-wake disturbance in patients with chronic liver disease. Hepatol Res 2022;52:327-8. [PMID: 35366385 DOI: 10.1111/hepr.13760] [Reference Citation Analysis]
16 Ryu E, Xia HH, Guo GL, Zhang L. Multivariable-adjusted trends in mortality due to alcoholic liver disease among adults in the United States, from 1999-2017. Am J Transl Res 2022;14:1092-9. [PMID: 35273712] [Reference Citation Analysis]
17 Kaibori M, Hiraoka A, Matsui K, Matsushima H, Kosaka H, Yamamoto H, Yamaguchi T, Yoshida K, Sekimoto M. Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases. Cancers (Basel) 2022;14:1402. [PMID: 35326554 DOI: 10.3390/cancers14061402] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yokoyama K, Sakamaki A, Takahashi K, Naruse T, Sato C, Kawata Y, Tominaga K, Abe H, Sato H, Tsuchiya A, Kamimura K, Takamura M, Yokoyama J, Terai S. Hydrogen-producing small intestinal bacterial overgrowth is associated with hepatic encephalopathy and liver function. PLoS One 2022;17:e0264459. [PMID: 35213654 DOI: 10.1371/journal.pone.0264459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen XY, Wang C, Huang YZ, Zhang LL. Nonalcoholic fatty liver disease shows significant sex dimorphism. World J Clin Cases 2022; 10(5): 1457-1472 [DOI: 10.12998/wjcc.v10.i5.1457] [Reference Citation Analysis]
20 Tatsumi A, Maekawa S, Osawa L, Katoh R, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Takahashi E, Miura M, Amemiya F, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Okada H, Araki T, Onishi H, Enomoto N. Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration. JGH Open. [DOI: 10.1002/jgh3.12712] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Kishimoto R, Suga M, Usumura M, Iijima H, Yoshida M, Hachiya H, Shiina T, Yamakawa M, Konno K, Obata T, Yamaguchi T. Shear wave speed measurement bias in a viscoelastic phantom across six ultrasound elastography systems: a comparative study with transient elastography and magnetic resonance elastography. J Med Ultrasonics. [DOI: 10.1007/s10396-022-01190-x] [Reference Citation Analysis]
22 Takaya H, Namisaki T, Matsumoto K, Suzuki J, Murata K, Tsuji Y, Nakanishi K, Kaji K, Kitade M, Noguchi R, Yoshiji H. Comparison of Ablation Area and Change in Functional Liver Reserve after Radiofrequency Ablation for Hepatocellular Carcinoma Using the arfa® and VIVA® Systems. J Clin Med 2022;11:434. [PMID: 35054128 DOI: 10.3390/jcm11020434] [Reference Citation Analysis]
23 Hsu LI, Chen JW, Lin DT, Wei ST, Hou SM. The continued decline of plasma transfusions in Taiwan: An 11-year population-based study. Vox Sang 2021. [PMID: 34905221 DOI: 10.1111/vox.13222] [Reference Citation Analysis]
24 Obara K. Endoscopic treatment of esophagogastric varices. Dig Endosc 2021. [PMID: 34719803 DOI: 10.1111/den.14166] [Reference Citation Analysis]
25 Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS; HRS-HARMONY study investigators. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis 2021:S0272-6386(21)00890-8. [PMID: 34606933 DOI: 10.1053/j.ajkd.2021.08.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Feng S, Tong H, Gao JH, Tang SH, Yang WJ, Wang GM, Zhou HY, Wen SL. Anti-inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats. Exp Ther Med 2021;22:1213. [PMID: 34584558 DOI: 10.3892/etm.2021.10647] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Reference Citation Analysis]